Sanofi said it entered into talks with Clayton Dubilier & Rice to offload a controlling stake in its consumer-health division, leaning toward a partial sale to a private-equity firm rather than a ...

The French drugmaker laid out plans to separate its consumer division--home to brands such as Allegra, Dulcolax and IcyHot--from its innovative medicines and vaccines businesses a year ago. With its ...

Sanofi SA is in talks to sell a 50% controlling stake in its consumer health unit to Clayton Dubilier & Rice, in what is set ...

PARIS (Reuters) -Sanofi has entered into talks to sell a controlling 50% stake in its consumer health business Opella to U.S.

EUROPEAN shares closed lower on Thursday (Oct 10), with defence and industrial stocks leading losses, after data showed US inflation ticked higher, while investors waited for France to unveil its 2025 ...

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...

European shares ended slightly lower, driven by losses in defence and industrial sectors, amid rising U.S. inflation and ...

European shares closed lower on Thursday, with defence and industrial stocks leading losses, after data showed U.S. inflation ...

With one eye on the French government's 2025 budget later on Thursday - which is set to deliver some 60 billion euros ($65.68 billion) worth of tax hikes and spending cuts to tackle the fiscal deficit ...

British pharmaceutical company GSK said Wednesday it has agreed to pay $2.3 billion in the United States to put an end to lawsuits alleging that its Zantac heartburn drug caused cancer.

British pharmaceutical company GSK said Wednesday it has agreed to pay $2.3 billion in the United States to put an end to lawsuits alleging that its Zantac heartburn drug caused cancer.